Expanding the collection of Head and Neck Cancer Biobank for Discovery and Development of Novel Head and Neck Cancer Biomarkers and Therapies
What is the issue for NSW?
Head and Neck Cancer is significantly over represented in lower socioeconomic and indigenous population. Head and Neck cancers and their management lead to loss of several critical structures required for breathing, swallowing and vision. Despite the high morbidity and adverse psychosocial impact, there has been comparatively little investment in clinical trials, drug therapies, or screening for Head and Neck Cancer.
What does the research aim to do and how?
This study aims to support collection of pre and post therapy head and neck cancer tissues, normal tissues, metastatic samples and timed blood samples from Head and Neck cancer patients to form a research asset for future biomarker discovery, clinical trials and inform development of treatment strategies.